MedTrace Logo

Acceleration Drills and Change in Direction Drills on Agility, Speed and Performance in Squash Players

NCT06661226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-10-30

No results posted yet for this study

Summary

Squash match play is characterized by fast and frenetic movements, making the development of agility and speed crucial for players. The majority of movements in squash involve only 2 or 3 steps, emphasizing the need for quick and explosive movement execution.

It is a randomized clinical trial with non-probability convenience sampling technique. The sample size of the study is 28. It will be conducted in Punjab Squash Association in Lahore within 6 months after approval of synopsis. Group A will receive acceleration drills in 15-minute sessions for 6 weeks. 3-5 days per week with moderate to high intensity. Group B will receive change in direction drills (15-minute sessions) for 6 weeks, 3-5 times a week, with moderate to high intensity. The collected data will be analyzed in Statistical Package for the Social Sciences (SPSS) 25.0. If data will be normally distributed, then parametric; if not normally distributed, then non-parametric.

The aim of the study is to compare the effects of acceleration drills versus change in direction drills on agility, speed, and performance in squash players.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Accleration drills

14 participants will be in experimental group A, giving them acceleration drill protocol for six weeks. Measure all values before giving them protocol and after protocol.

OTHER

Change in Direction Drills

14 participants will be in experimental group B, giving them Change in direction drill protocol for six weeks. Measure all values before giving them protocol and after protocol.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Aamir Gul Memon, MS · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-08-01
Completion
2024-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06661226 on ClinicalTrials.gov